(AGENPARL) – WORCESTER (MASSACHUSETTS), mer 03 febbraio 2021 (Fundação de Amparo à Pesquisa do Estado de São Paulo) Technology based on nanoparticles identifies IgG antibodies and costs only about a fifth of similar devices now on the market. It was developed by scientists at the University of São Paulo and Brazilian startup Biolinker.
Fonte/Source: https://www.eurekalert.org/pub_releases/2021-02/fda-rd1020221.php
Essa notícia também repercutiu nos veículos:
Globe Health News
7thSpace
Bioengineer (Reino Unido)
Biotech Asia News (Índia)
Scienmag Science Magazine (Reino Unido)
News Medical (Austrália)
Corona Stocks (Canadá)
InfoSurHoy (EUA)
Medical Xpress (Reino Unido)
Health Problems News
BioTech.WS
Biotech World
Vighneshworld.com
Yes Health Please (EUA)
Family Health Tale
Medical Advise (EUA)